STAT

JANUARY 17, 2024

The failure of Geisinger Health System, which lost $842 million in 2022 and disappeared into a new Kaiser subsidiary called Risant, sent shockwaves through the health care community in the spring of 2023. Founded in 1919, Geisinger was in the vanguard of the so-called “value-based care” movement. It sponsored a regionally significant 600,000-member health plan and served as the home of an exceptionally high-quality 1,600-person multispecialty medical group.

Hospitals 324

Hospitals 324

PharmaVoice

JANUARY 17, 2024

The infectious disease market could be shifting toward a future not only focused on the microbe, but on the unique genetic attributes of the host.

246

246

STAT

JANUARY 17, 2024

Researchers from the University of California San Diego School of Medicine say a new method can better predict the quality of embryos used for in vitro fertilization, potentially raising the odds of a successful pregnancy for those relying on assisted reproductive technology.  For people struggling with infertility, IVF — which involves retrieving eggs and fertilizing them in the lab before implanting embryos in the uterus — often provides hope.

323

323

The Pharmacist

JANUARY 17, 2024

Pharmacists employed by primary care networks (PCNs) should be deployed to work ‘where they are needed’ and across multiple settings, including in community pharmacies, the chair of the Pharmacists’ Defence Association (PDA) has suggested. Giving evidence to the Health and Social Care Committee (HSCC)’s pharmacy inquiry yesterday, Mark Koziol proposed using Additional Roles Reimbursement Scheme […] The post Call for PCNs to deploy pharmacists across multiple settings appeared first on The

Community Pharmacies 126

Community Pharmacies 126

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 17, 2024

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots. Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early. The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level.

315

315

The Pharmacist

JANUARY 17, 2024

Male patients taking valproate have been urged to speak to their healthcare professional if they are planning to have children in the next year. This comes as the UK medicines regulator considers new evidence suggesting that children whose fathers took valproate are at increased risk of neurodevelopmental disorders. A new study, commissioned by the European […] The post MHRA urges caution for men taking valproate appeared first on The Pharmacist.

122

122

BioPharma Dive

JANUARY 17, 2024

The offering is the fifth outlined by a biotech startup this month, suggesting companies are becoming more willing to gauge investors’ appetite for new stock offerings.

121

121

STAT

JANUARY 17, 2024

Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth has made it easy to schedule a virtual visit and get a script, sometimes within minutes, with prescriptions shipped to your doorstep. Now, Big Pharma is ready to get in on the action. In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medic

Online Pharmacies 292

Online Pharmacies Diabetes 292

BioPharma Dive

JANUARY 17, 2024

The startup is focusing on immune cells called Tr1 cells, which it claims could be important in treating autoimmune conditions like graft-versus-host disease.

Immunity 122

Immunity Immunization 122

STAT

JANUARY 17, 2024

The chemotherapy Christine Ko was prescribed for her breast cancer is pretty much a guarantee for losing your hair. The intervention her doctors offered to prevent the hair loss was a cold cap that, cooled to 32 degrees Fahrenheit, would turn her scalp into an icy crown. But, to her, it wasn’t much of an option. “It would cost about $2,000, and it’s about 50% effective.

Chemotherapy 274

Chemotherapy Drug Development 274

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

JANUARY 17, 2024

The disparity in access to healthcare between women and men around the world is often talked about but has never been given a dollar value – until now.

121

121

STAT

JANUARY 17, 2024

Testosterone is essential for bone health in men. It helps maintain bone density and improve bone microarchitecture, preventing fractures. So treating older men with hypogonadism — a condition that causes low testosterone levels — with the hormone should decrease their likelihood of getting fractures, right? Surprisingly not, according to a study published Wednesday in the New England Journal of Medicine.

233

233

pharmaphorum

JANUARY 17, 2024

Scotland's expertise in advanced therapies, combined with its robust healthcare system and strong research infrastructure, positions it as a leader in tackling complex diseases such as lung, liver, and vascular disorders. Discover why Scotland is at the forefront of innovation and advancements in this field.

109

109

STAT

JANUARY 17, 2024

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today is butter pecan, a household favorite — and get started. Meanwhile, do keep us in mind if you hear anything interesting.

219

219

pharmaphorum

JANUARY 17, 2024

Oral cytisine therapy for smoking cessation from Consilient Health will launch in the UK next week, helping to alleviate a shortage of prescription drugs to help people quit

109

109

STAT

JANUARY 17, 2024

Venture capital firm General Catalyst has agreed to acquire Ohio-based nonprofit health system Summa Health and reestablish it as a for-profit organization, the health system’s board of directors announced Wednesday. General Catalyst announced plans in October to buy a health system and use it as a proving ground for the technology developed by its portfolio companies, especially after finding that health systems are risk averse and slow to adopt new products that could potentially improv

Hospitals 194

Hospitals 194

Express Pharma

JANUARY 17, 2024

Zeon Lifesciences, a contract research and manufacturing (CRAMS) organisation in the nutrition wellness and ayurvedic product space, has secured a patent for its “Synergistic Herbal Immunomodulatory Formulation”. The company informed that the formulation comprises ingredients that are registered with the Food Safety and Standards Authority of India (FSSAI).

Immunity 108

Immunity Immunization 108

STAT

JANUARY 17, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the latest biotech startup to downsize, a novel idea in cancer treatment, and a few major catalysts on the calendar.

Drug Pricing 188

Drug Pricing Drug Development 188

pharmaphorum

JANUARY 17, 2024

Stay up to date on the latest clinical trials happening in the week of 8th-12th January. Get information on trials for Lytix Biopharma's Verrica, Celletcar, Ariceum, Dermavant, BI, and more.

106

106

Med Ed 101

JANUARY 17, 2024

In the challenging world of pharmacology, recognizing drug interactions is paramount to ensuring patient safety and optimal treatment outcomes. To make this complex subject more engaging and accessible, we’ve introduced a unique approach – a crossword puzzle that challenges both healthcare professionals and enthusiasts to navigate the labyrinth of drug interactions.

104

104

Pharmaceutical Business Review

JANUARY 17, 2024

This label update is based on findings from the Phase III LIBERTY-AD-HAFT trial, the first to evaluate a biologic for this patient group. Dupixent, a fully human monoclonal antibody, inhibits the signalling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways. It is not an immunosuppressant. The development programme for Dupixent has highlighted its significant clinical benefit and its role in decreasing type 2 inflammation in multiple related diseases.

Labelling 103

Labelling 103

World Pharma News

JANUARY 17, 2024

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted marketing authorisation for Tecentriq® SC (atezolizumab), the European Union (EU)'s first PD-(L)1 cancer immunotherapy for subcutaneous (under the skin) injection.

99

99

pharmaphorum

JANUARY 17, 2024

The US patent office has invalidated the only Seagen patent cited in a lawsuit claiming infringement by Daiichi Sankyo’s breast cancer therapy Enhertu.

103

103

Express Pharma

JANUARY 17, 2024

Sun Pharmaceutical Industries and Bayer have signed an agreement to market and distribute a second brand of Finerenone in India. Finerenone is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalisation for heart failure in adult patients with chronic kidney disease associated with type 2 diabetes mellitus.

Diabetes 92

Diabetes 92

pharmaphorum

JANUARY 17, 2024

FDA has approved Vertex and CRISPR Therapeutics' Casgevy as first CRISPR based therapy for transfusion-dependent thalassaemia.

111

111

Welltopia Pharmacy

JANUARY 17, 2024

Topical Metformin: A New Era in Diabetes Care Understanding Diabetes: Types and Prevalence Diabetes, a chronic condition affecting millions worldwide,

Diabetes 100

Diabetes Compounding 100

pharmaphorum

JANUARY 17, 2024

US federal court renews ban on Apple Watches with blood oxygen feature that infringes patents held by Masimo, but tech giant says it has a workaround

99

99

Pharmaceutical Technology

JANUARY 17, 2024

Coya plans to file investigational new drug applications for COYA 302 in amyotrophic lateral sclerosis and frontotemporal dementia later this year.

98

98

pharmaphorum

JANUARY 17, 2024

New technologies have revolutionised brand planning and strategy development, making it easier than ever to create and execute effective brand plans. Explore how these technologies simplify the brand planning process and maximise success.

89

89

Pharmaceutical Technology

JANUARY 17, 2024

Takeda has gained approval from the US Food and Drug Administration for HYQVIA to treat chronic inflammatory demyelinating polyneuropathy.

98

98

The Pharmacist

JANUARY 17, 2024

The requirement for foundation trainee pharmacists to have a ‘nominated prescribing area’ has raised questions among the sector about what this could consist of, as well as fresh concerns about the capacity of the profession to supervise them. NHS England (NHSE) guidance released this month asks pharmacists undertaking their foundation year from 2025/26 to demonstrate […] The post Trainee pharmacists must have ‘nominated prescribing area’ appeared first on The Pharmacist.

91

91

Pharma Times

JANUARY 17, 2024

License agreement concerns development of cell therapies for corneal blindness

116

116

European Pharmaceutical Review

JANUARY 17, 2024

The small molecule heart failure drug acoramidis has potential in slowing or stopping the progression of transthyretin amyloid cardiomyopathy (ATTR-CM), according to study data published in the New England Journal of Medicine. Findings from the Phase III trial ATTRibute-CM showed the novel drug is safe and can achieve near-complete stabilisation of TTR proteins, which play a key role in disease progression of ATTR-CM.

81

81

Pharmaceutical Technology

JANUARY 17, 2024

The US FDA has approved Vertex's CASGEVY, a gene-edited cell therapy, to treat transfusion-dependent beta thalassemia.

98

98

Outsourcing Pharma

JANUARY 17, 2024

After visiting Biofourmis in Boston last year, OSP was impressed with the remote care the company could offer people from the comfort of their own homes.

105

105